1. Home
  2. QLGN vs AUUD Comparison

QLGN vs AUUD Comparison

Compare QLGN & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • AUUD
  • Stock Information
  • Founded
  • QLGN 1996
  • AUUD 2012
  • Country
  • QLGN United States
  • AUUD United States
  • Employees
  • QLGN 4
  • AUUD N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • AUUD Computer Software: Prepackaged Software
  • Sector
  • QLGN Health Care
  • AUUD Technology
  • Exchange
  • QLGN Nasdaq
  • AUUD Nasdaq
  • Market Cap
  • QLGN 2.7M
  • AUUD 3.1M
  • IPO Year
  • QLGN N/A
  • AUUD 2021
  • Fundamental
  • Price
  • QLGN $3.60
  • AUUD $0.51
  • Analyst Decision
  • QLGN
  • AUUD
  • Analyst Count
  • QLGN 0
  • AUUD 0
  • Target Price
  • QLGN N/A
  • AUUD N/A
  • AVG Volume (30 Days)
  • QLGN 226.0K
  • AUUD 115.3K
  • Earning Date
  • QLGN 11-29-2024
  • AUUD 11-07-2024
  • Dividend Yield
  • QLGN N/A
  • AUUD N/A
  • EPS Growth
  • QLGN N/A
  • AUUD N/A
  • EPS
  • QLGN N/A
  • AUUD N/A
  • Revenue
  • QLGN N/A
  • AUUD N/A
  • Revenue This Year
  • QLGN N/A
  • AUUD N/A
  • Revenue Next Year
  • QLGN N/A
  • AUUD N/A
  • P/E Ratio
  • QLGN N/A
  • AUUD N/A
  • Revenue Growth
  • QLGN N/A
  • AUUD N/A
  • 52 Week Low
  • QLGN $3.55
  • AUUD $0.48
  • 52 Week High
  • QLGN $39.15
  • AUUD $11.75
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 25.42
  • AUUD 35.17
  • Support Level
  • QLGN $3.71
  • AUUD $0.53
  • Resistance Level
  • QLGN $4.56
  • AUUD $0.61
  • Average True Range (ATR)
  • QLGN 0.65
  • AUUD 0.05
  • MACD
  • QLGN -0.06
  • AUUD -0.00
  • Stochastic Oscillator
  • QLGN 2.08
  • AUUD 16.06

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About AUUD Auddia Inc.

Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.

Share on Social Networks: